Diabetes Research and Clinical Practice
Volume 57, Issue 1 , Pages 45-51 , July 2002

Insensate versus painful diabetic neuropathy: the effects of height, gender, ethnicity and glycaemic control

  • Lea Sorensen

      Affiliations

    • Department of Medicine, University of Sydney, Newtown, NSW 2042, Australia
    • Diabetes Centre, Royal Prince Alfred Hospital, Level 10, Queen Mary Building, Grose Street, Camperdown, NSW 2050, Australia
    • Corresponding Author InformationCorresponding author. Tel.: +61-2-9515-3737; fax: +61-2-9515-3750
    • ,
  • Lynda Molyneaux

      Affiliations

    • Diabetes Centre, Royal Prince Alfred Hospital, Level 10, Queen Mary Building, Grose Street, Camperdown, NSW 2050, Australia
    • ,
  • Dennis K. Yue

      Affiliations

    • Department of Medicine, University of Sydney, Newtown, NSW 2042, Australia
    • Diabetes Centre, Royal Prince Alfred Hospital, Level 10, Queen Mary Building, Grose Street, Camperdown, NSW 2050, Australia

,Accepted 8 January 2002.

References 

  1. Dyck PJ, Thomas PK. Diabetic Neuropathy. second ed.. Philadelphia, London: WB Saunders; 1999;
  2. Boulton AJ, Kubrusly DB, Bowker JH, et al.  Impaired vibratory perception and diabetic foot ulceration. Diabetic Med. 1986;3:335–337
  3. McGill M, Molyneaux L, Yue DK. Use of the Semmes Weinstein 5.07/10 g monofilament: the long and the short of it. Diabetic Med. 1998;15:615–617
  4. Britland ST, Young RJ, Ashutosh KS, Clarke BF. Association of painful and painless diabetic polyneuropathy with different patterns of nerve fibre degeneration and regeneration. Diabetes. 1990;39:898–908
  5. Sosenko JM, Gadia MT, Fournier AM, O'Connell MT, Aguiar MC, Skyler JS. Body stature as a risk factor for diabetic neuropathy. Am. J. Med. 1986;80:1031–1034
  6. Gadia MT, Natori N, Ramos LB, Ayyar R, Skyler JS, Sosenko JM. Influence of height on quantitative sensory, nerve-conduction and clinical indices of diabetic peripheral neuropathy. Diabetes Care. 1987;10:613–616
  7. Cohen JA, Jeffers BW, Faldut D, Marcoux M, Schrier RW. Risks for sensorimotor peripheral neuropathy and autonomic neuropathy in non-insulin dependent diabetes mellitus. Muscle Nerve. 1998;21:72–80
  8. Dray A, Rang H. The how and why of chronic pain states and the what of new analgesia therapies. Trends Neurosci. 1998;21:315–317
  9. Canaver S, Bonicalzi V. The neurochemistry of central pain: evidence from clinical studies, hypothesis and therapeutic implications. Pain. 1998;74:109–114
  10. Gibson SJ, Helme RD. Cognitive factors and the experience of pain and suffering in older persons. Pain. 2000;85:375–383
  11. Loeser JD. Perils in the pursuit of mechanisms. Pain. 2000;86:1
  12. Junger H, Sorkin LS. Nociceptive and inflammatory effects of subcutaneous TNFα. Pain. 2000;85:145–151
  13. Dyck PJ, Dyck PJB, Velosa JA, et al.  Patterns of quantitative sensation testing of hypoaesthesia and hyperalgaesia are predictive of diabetic polyneuropathy. Diabetes Care. 2000;23:510–517

PII: S0168-8227(02)00010-4

Diabetes Research and Clinical Practice
Volume 57, Issue 1 , Pages 45-51 , July 2002

Article Tools

* Image Usage & Resolution